1
|
Miendje Deyi V, Mori M, Dauby N, Clevenbergh P, Mahadeb B, Loizidou A, Maillart E, Martiny D, Debyttere A, Gerard M, Hallin M. Staggered enforcement of infection control and prevention measures following four consecutive potential laboratory exposures to imported Brucella melitensis. Infect Prev Pract 2021; 3:100128. [PMID: 34368745 PMCID: PMC8336054 DOI: 10.1016/j.infpip.2021.100128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2020] [Accepted: 02/12/2021] [Indexed: 11/15/2022] Open
Abstract
From 2015 until 2020, Brucella melitensis was isolated four times in our microbiology laboratory. All patients had travelled in endemic-areas. Immediately after the first occurrence, all laboratory staff were risk-stratified and preventive and protective measures were applied according to CDC guidelines. Nineteen workers were exposed and needed chemoprophylaxis and follow-up. At each subsequent occurrence, risk analysis was performed, and additional measures were implemented accordingly, leading to a progressive reduction of exposed staff members to none the fourth time. We describe here the additional measures that permitted this important exposure reduction.
Collapse
Affiliation(s)
- V.Y. Miendje Deyi
- Laboratoire Hospitalier Universitaire de Bruxelles – Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium
- Corresponding author. Address: LHUB-ULB, Microbiology Department, 322 Rue Haute, 1000, Bruxelles, Belgium. Tel.: +32 2 435 20 40; fax: +32 2 435 20 39.
| | - M. Mori
- National Reference Centre (NRC) for Brucella spp, Sciensano, Brussels, Belgium
| | - N. Dauby
- Department of Infectious Diseases, Centre Hospitalier Universitaire (CHU) Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium
- Environmental Health Research Centre, Public Health School, Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - P. Clevenbergh
- Department of Internal Medicine and Infectious Diseases, Centre Hospitalier Universitaire (CHU) Brugmann, Brussels, Belgium
| | - B. Mahadeb
- Laboratoire Hospitalier Universitaire de Bruxelles – Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium
| | - A. Loizidou
- Department of Internal Medicine and Infectious Diseases, Institut Jules Bordet, Brussels, Belgium
| | - E. Maillart
- Department of Internal Medicine and Infectious Diseases, Centre Hospitalier Universitaire (CHU) Brugmann, Brussels, Belgium
| | - D. Martiny
- Laboratoire Hospitalier Universitaire de Bruxelles – Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium
| | - A.L. Debyttere
- Laboratoire Hospitalier Universitaire de Bruxelles – Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium
| | - M. Gerard
- Infection Control Unit, Centre Hospitalier Universitaire (CHU) Saint-Pierre, Brussels, Belgium
| | - M. Hallin
- Laboratoire Hospitalier Universitaire de Bruxelles – Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium
| |
Collapse
|